GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CFO Sells Highlight: AthenaHealth Inc, Gilead Sciences Inc, JPMorgan Chase & Co.

April 20, 2014 | About:
Myra Ramdenbourg

Myra Ramdenbourg

0 followers

According to GuruFocus Insider Data, the recent CFO sales were: AthenaHealth Inc, Gilead Sciences Inc, and JPMorgan Chase & Co.

AthenaHealth Inc (ATHN): CFO and SVP Timothy M Adams sold 30,000 Shares

On 02/18/2014, CFO and SVP Timothy M Adams sold 30,000 shares at an average price of $194.58. The price of the stock has decreased by 25.18% since. AthenaHealth Inc. has a market cap of $5.44 billion and its shares were traded at around $145.58. The company has a P/E ratio of 8563.70 and P/S ratio of 9.40. Over the past 5 years, AthenaHealth Inc. had an annual average earnings growth of 23.90%.

AthenaHealth Inc announced their 2014 fourth quarter results with revenues of $171.58 million and gross profit of $108.7 million; the net income was $13.1 million. The 2013 total revenue was $595 million, a 41% increase from the 2012 total revenue. The 2013 gross profit was $356.3 million, a 40% increase from the 2012 gross profit. The 2013 net income was $2.6 million.

On 04/02/2014, CEO and President Jonathan Bush sold 1,000 shares at an average price of $161.74. The price of the stock has decreased by 9.99% since. On 04/16/2014, President, Enterprise Services Stephen N Kahane sold 10,000 shares at an average price of $143.96. The price of the stock has increased by 1.13% since. On 04/14/2014, Director David Eric Robinson sold 60,000 shares at an average price of $140.61. The price of the stock has increased by 3.53% since.

Gilead Sciences Inc (GILD): EVP, CFO Robin L Washington sold 30,600 Shares

On 02/28/2014, EVP, CFO Robin L Washington sold 30,600 shares at an average price of $83.65. The price of the stock has decreased by 16.32% since. Gilead Sciences Inc has a market cap of $107.68 billion and its shares were traded at around $70,000 with a P/E ratio of 38.30 and P/S ratio of 10.60. Over the past 5 years, Gilead Sciences Inc had an annual average earnings growth of 8.20%.

Gilead Sciences Inc announced their 2013 fourth quarter results with revenues of $3.12 billion and gross profit of $2.26 billion; the net income $781.4 million. The 2013 total revenue was $11.2 billion, a 15% increase. The 2013 gross profit was $8.34 billion, a 15% increase from the 2012 gross profit. The 2013 net income was $3.1 billion.

On 04/14/2014, EVP, R&D and CSO Norbert W Bischofberger sold 90,000 shares at an average price of $67.03. The price of the stock has increased by 4.43% since. On 04/08/2014, EVP Commercial Ops Paul Rutherford Carter sold 16,728 shares at an average price of $70.53. The price of the stock has decreased by 0.75% since. On 04/08/2014, Director John Francis Cogan sold 5,000 shares at an average price of $70.55. The price of the stock has decreased by 0.78% since.

JPMorgan Chase & Co (JPM): CFO Marianna Lake sold 4,879 Shares

On 04/14/2014, CFO Marianne Lake sold 4,879 shares at an average price of $54.89. The price of the stock has increased by 0.6% since. JPMorgan Chase & Co has a market cap of $209.11 billion and its shares were traded at around $55.22. The company has a P/E ratio of 13.00 and P/S ratio of 2.20 with a dividend yield of 2.80%. Over the past 10 years, JPMorgan Chase & Co had an annual average earnings growth of 9.30%.

JPMorgan Chase & Co announced their 2013 fourth quarter results with a revenue and gross profit of $23.05 billion; the net income was $5.3 billion. The 2013 total revenue and gross profit of JPMorgan Chase & Co was $96.38 billion, a 3% increase from the 2012 total revenue and gross profit. The 2013 net income was $17.9 billion.

On 01/31/2014, Director James S Crown bought 500,000 shares at an average price of $55.54. The price of the stock has decreased by 0.56% since. On 04/14/2014, General Counsel Stephen M Cutler sold 43,997 shares at an average price of $54.91. The price of the stock has increased by 0.56% since. On 04/14/2014, Director Human Resources John L Donnelly sold 9,851 shares at an average price of $54.91. The price of the stock has increased by 0.55% since.


Rating: 0.0/5 (0 votes)

Comments

hansen.harlley
Hansen.harlley - 4 months ago
I think right now the stock is inexpensive on next year earnings. As more investors are optimistic about the company, the stock price is going to rally. The company has shown that despite huge payments of fines, it still is in a condition to pay off the dividends and might as well increase them. [goo.gl]

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK